The monitoring of diabetics by the pharmacist may contribute to the effectiveness of drug treatment and to improve their quality of life. This study will measure the impact of pharmacotherapeutic follow-up in diabetic patients. This will be a clinical trial, single blind, controlled, randomized, conducted in two units of pharmacies in Brazil. Only in the intervention group will be held the pharmacotherapeutic follow using a methodology called the practice of pharmaceutical care, which identifies and resolves problems related to drugs. The primary outcome is glycated hemoglobin, and secondary outcomes are baseline glucose, total cholesterol and its fractions (for example LDL), all these measures will be made in the intervention group and control group. Patients will be followed for 24 weeks, and the outcomes will be assessed up to 24 weeks. There will be a confidence interval of 95% and a significance of p \<0.05, and will use the Student t test, chi-square analysis of variance (ANOVA) and others if necessary. Expects good results and serve as a model for other researchers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
100
Patients will be followed by the pharmacist by the Pharmaceutical Care Practice
Universidade Estadual da Paraíba
João Pessoa, Paraíba, Brazil
Glycated Hemoglobin
average glycated hemoglobin over 24 weeks
Time frame: Up to 24 weeks
Fasting Glycemia
average fasting glycemia over 24 weeks
Time frame: Up to 24 weeks
Total Cholesterol
average total cholesterol over 24 weeks
Time frame: Up to 24 weeks
LDL Cholesterol
average LDL cholesterol over 24 weeks
Time frame: Up to 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.